MRSN

Mersana Therapeutics, Inc. · NASDAQ

Sector Health Technology
Industry Biotechnology
Website mersana.com
Employees(FY) 228
ISIN US59045L1061

Performance

+0.91%

+5.71%

+65.06%

-18.68%

-4.31%

YTD

+38.75%

Profile

Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet needs. The company develops XMT-1660, a B7-H4-targeted Dolasynthen ADC candidate; and XMT-2056, an immunosynthen ADC. It has a research and development collaborations with Janssen Biotech, Inc. and Merck KGaA, as well as collaboration agreement with Asana BioSciences, LLC for the development of ADC product candidates. The company was formerly known as Nanopharma Corp. and changed its name to Mersana Therapeutics, Inc. in November 2005. Mersana Therapeutics, Inc. was incorporated in 2001 and is headquartered in Cambridge, Massachusetts.

Advanced Technical Analysis

Technical Analysis of MRSN 2024-11-20

The Moving Average Score of 63 indicates a bullish sentiment, while the Oscillators Score of 43 and Technical Score of 53 suggest a more neutral outlook. Overall, the combined scores reflect a mixed sentiment, with a stronger bullish indication from the moving averages tempered by neutral signals from the oscillators and technical indicators.

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of MRSN

Stock Rank

Recent News & Updates

2024-11-13 13:06
Mersana Therapeutics Inc (MRSN) Q3 2024 Earnings Call Highlights: Strategic Advances and ...(Yahoo Finance)
2024-11-13 12:32
Q3 2024 Mersana Therapeutics Inc Earnings Call(Yahoo Finance)
2024-11-12 19:10
Mersana Therapeutics, Inc. (MRSN) Reports Q3 Loss, Tops Revenue Estimates(Yahoo Finance)
2024-11-12 18:00
Mersana Therapeutics Provides Business Update and Announces Third Quarter 2024 Financial Results(Globenewswire)
2024-11-05 19:00
Mersana Therapeutics to Host Third Quarter 2024 Conference Call on November 13, 2024(Globenewswire)
2024-10-14 23:01
SILVERARC CAPITAL MANAGEMENT, LLC Reduces Stake in Mersana Therapeutics Inc(Yahoo Finance)
2024-08-12 20:20
Mersana Therapeutics, Inc. (MRSN) Reports Q2 Loss, Misses Revenue Estimates(Yahoo Finance)
2024-08-12 19:00
Mersana Therapeutics Provides Business Update and Announces Second Quarter 2024 Financial Results(Globenewswire)
2024-08-05 20:00
Mersana Therapeutics to Host Second Quarter 2024 Conference Call on August 13, 2024(Globenewswire)
2024-05-21 20:00
Mersana Therapeutics to Present at Upcoming Investor Conferences(Globenewswire)
2024-05-10 04:36
Mersana Therapeutics, Inc. (NASDAQ:MRSN) Q1 2024 Earnings Call Transcript(Yahoo Finance)
2024-05-10 03:15
Mersana Therapeutics Inc (MRSN) Reports Q1 2024 Financial Results: A Detailed Analysis(Yahoo Finance)
2024-05-08 23:55
MRSN Stock Earnings: Mersana Therapeutics Beats EPS, Beats Revenue for Q1 2024(Investorplace)
2024-05-08 20:05
Mersana Therapeutics, Inc. (MRSN) Reports Q1 Loss, Misses Revenue Estimates(Zacks)
2024-05-08 20:05
Mersana Therapeutics, Inc. (MRSN) Reports Q1 Loss, Misses Revenue Estimates(Yahoo Finance)
2024-05-08 18:59
Mersana Therapeutics Provides Business Update and Announces First Quarter 2024 Financial Results(Globenewswire)
2024-05-03 04:30
Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)(Globenewswire)
2024-05-01 20:00
Mersana Therapeutics to Host First Quarter 2024 Conference Call on May 9, 2024(Globenewswire)
2024-04-05 08:43
Strength Seen in Curis (CRIS): Can Its 19.5% Jump Turn into More Strength?(Zacks)
2024-04-04 16:30
Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)(GlobeNewswire)
2024-04-04 04:30
Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)(Globenewswire)
2024-02-29 08:41
Mersana Therapeutics, Inc. (NASDAQ:MRSN) Q4 2023 Earnings Call Transcript(Insider Monkey)
2024-02-29 06:34
An Intrinsic Calculation For Mersana Therapeutics, Inc. (NASDAQ:MRSN) Suggests It's 26% Undervalued(Simply Wall St.)
2024-02-29 06:19
Mersana Therapeutics Full Year 2023 Earnings: Revenues Disappoint(Simply Wall St.)
2024-02-28 21:49
Q4 2023 Mersana Therapeutics Inc Earnings Call(Thomson Reuters StreetEvents)
2024-02-28 08:10
Mersana Therapeutics, Inc. (MRSN) Reports Q4 Loss, Lags Revenue Estimates(Zacks)
2024-02-28 07:35
Mersana Therapeutics Inc (MRSN) Reports Fourth Quarter and Full Year 2023 Financial Results(GuruFocus.com)
2024-02-28 07:00
Mersana Therapeutics Provides Business Update and Announces Fourth Quarter and Full Year 2023 Financial Results(GlobeNewswire)
2024-02-27 19:10
Mersana Therapeutics, Inc. (MRSN) Reports Q4 Loss, Lags Revenue Estimates(Zacks)
2024-02-27 18:00
Mersana Therapeutics Provides Business Update and Announces Fourth Quarter and Full Year 2023 Financial Results(Globenewswire)

Page 1 of 5

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.